Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced or Metastatic Solid Malignancies × sitravatinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Lung Diseases 1 Esophageal Squamous Cell Carcinoma 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Advanced or Metastatic Solid Malignancies 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

sitravatinib 1 pembrolizumab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04887870 2025-10-10

Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study

Mirati Therapeutics Inc.

Phase 2/3 Completed

Advanced or Metastatic Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡